Adriaan Moelker (M)
Vorstandsvorsitzender BRAIN Biotech AG
I am proud to affirm our commitment to advancing gender equality and the empowerment of women in the workplace, marketplace, and community. We recognize that gender equality is not only a moral imperative but also a driver of business success. As a participant of the 6th round of the UN Global Target Gender Accelerator Program, BRAIN Biotech AG examined this topic in depth, increased internal visibility, and derived concrete measures. The resulting WEPs action plan is fully aligned with our integrated ESG-strategy, ensuring initiatives are implemented group-wide and that diversity and gender equality are embedded across all business areas.
General Information
WEPs signatory since 18 February 2026
Public
201-500 employees
Industry
Biotechnology
Location
Germany
Europe and Central Asia
Also operating and will implement WEPs in the following countries and regions:
Other Countries
Netherlands
United Kingdom of Great Britain and Northern Ireland
United States of America